Haemonetics (HAE) Capital Expenditures Growth (5y) (2014 - 2026)
Haemonetics (HAE) Capital Expenditures Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Haemonetics | 3.78 Bn | 3.53 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 8.71% |
| Dec 27, 2025 | -7.49% |
| Sep 27, 2025 | -9.67% |
| Jun 28, 2025 | -13.37% |
| Mar 29, 2025 | 8.00% |
| Dec 28, 2024 | -15.96% |
| Sep 28, 2024 | -0.08% |
| Jun 29, 2024 | -7.27% |
| Mar 30, 2024 | -13.39% |
| Dec 30, 2023 | -12.92% |
| Sep 30, 2023 | -28.42% |
| Jul 1, 2023 | -22.52% |
| Apr 1, 2023 | 37.25% |
| Dec 31, 2022 | -8.71% |
| Oct 1, 2022 | 18.48% |
| Jul 2, 2022 | 27.08% |
| Apr 2, 2022 | 17.59% |
| Jan 1, 2022 | 7.13% |
| Oct 2, 2021 | 1.68% |
| Jul 3, 2021 | -9.14% |